Benzonatate compositions and methods of use
Oral dosage forms of benzonatate useful for anti-tussive and anti-tussive/combination applications.
1. A solid oral dosage form of a pharmaceutical composition comprising benzonatate bound to at least one member of the group consisting of a strong acid ion exchange resin, a weak acid ion exchange resin and their combination to form a resinate; said solid oral dosage form additionally comprising a noxious tasting agent selected from the group consisting of denatonium benzoate, cayenne pepper, capsaicin and their combination; wherein said oral dosage form is useful for reducing or preventing adverse effects caused by the release of benzonatate into the oral cavity.
2. The solid oral dosage form of claim 1 comprising at least one additional pharmaceutically active agent.
3. The solid oral dosage form of claim 1 , wherein at least two pharmaceutically active agents are bound to at least one ion exchange resin.
4. The solid oral dosage form according to claim 1 , wherein said oral dosage form is useful for reducing or preventing sucking or chewing which may cause adverse effects caused by the release of benzonatate into the oral cavity.
5. A solid oral dosage form according to claim 1 comprising benzonatate bound to a weak acid ion exchange resin.
6. A solid oral dosage form according to claim 1 comprising benzonatate bound to a strong acid ion exchange resin.
7. A solid oral dosage form according to claim 1 comprising: (i) benzonatate bound to a strong acid ion exchange resin; and (ii) benzonatate bound to a weak acid ion exchange resin.
8. A solid oral dosage form of a pharmaceutical composition comprising: (i) benzonatate bound to a first ion exchange resin; (ii) benzonatate bound to a second ion exchange resin; wherein said first and second ion exchange resins are members of the group consisting of a strong acid ion exchange resin, a weak acid ion exchange resin and their combination; said solid oral dosage form additionally comprising a noxious tasting agent selected from the group consisting of denatonium benzoate, cayenne pepper, capsaicin and their combination; wherein said oral dosage form is useful for reducing or preventing adverse effects caused by the release of benzonatate into the oral cavity; and wherein said benzonatate bound second ion exchange resin is coated with an extended release coating.
9. A method of treating a cough while reducing or preventing adverse effects caused by a release of benzonatate into the oral cavity comprising treating a patient with a solid oral dosage form as described in claim 1 .
10. A method of treating a cough while reducing or preventing adverse effects caused by a release of benzonatate into the oral cavity comprising treating a patient with a solid oral dosage form as described in claim 8 .